Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

Cancer shared this article with you from Inoreader Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer Via MedWorm Cancer & Oncology Clinical Trials Condition:   HER2-positive Breast Cancer Intervention:   Other: Blood sample for genetic analysis Sponsor:   Institut de cancérologie Strasbourg Europe Not yet recruiting (Source: ClinicalTrials.gov) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.